Paris Brain Institute was established in 2010, and was created as a collaborative, interdisciplinary research model that promotes innovation and groundbreaking discoveries. This environment, in which patients, researchers, clinicians, engineers, technicians, business leaders and students work side by side, has become a Europe’s leading center for research into the central nervous system.
-
846 employees including 83% scientific, medical and paramedical staff (at 30 September 2023)
-
45 nationalities different (at 30 September 2023)
-
27 research teams selected by an international scientific advisory board
-
11 technology platforms and biobank (at 30 September 2023)
-
586 publications in international scientific journals in 2023 (calendar year)
-
573 patient inclusions in Neuroscience CIC trials (to 30 September 2023)
-
88 clinical trials in progress at the CIC Neurosciences, including 13 promoted by Paris Brain Institute (as at 30 September 2023)
-
13 clinical research infrastructures (Icrins) (at 30 September 2023)
-
16 training programmes at the Open Brain School (at 30 September 2023)
-
95 134 active donors between 1 October 2022 and 30 September 2023
-
58 active patents including 8 new patents filed and software protected (over the period from 1 October 2022 to 30 September 2023)
-
29 start-ups incubated in the iPEPS incubator, including 5 new start-ups (by 30 September 2023)
-
62 industrial contracts (to 30 September 2023)
